Unknown NA INTERVENTIONAL 2-arm NCT01520974

Effect of an Oral Probiotic Tablet on Oral Bacteria and Clinical Measurements (ProBiora3)

ProBiora3 Oral Care Probiotics Usage

Sponsor: Oragenics, Inc.

Interventions Placebo tablet ProBiora3 mints

Updated 5 times since 2017 Last updated: May 1, 2012 Started: Jan 31, 2012 Primary completion: Aug 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Oral Health, this trial is ongoing. The trial is conducted by Oragenics, Inc. and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oragenics, Inc.
University of Washington

Data source: Oragenics, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seattle, United States